Ashish Kacholia recent bets

Morgan Stanley recent bets

Recent Big Buys

Top deal-making stocks

Most insider traded stocks

Leading investors

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Hasn't fared well - amongst the low performers

Average profitability - not good, not bad

Not a good time to consider, stock is in the overbought zone

The ETF tracks Nifty Pharma Index which is designed to reflect the behavior and performance of the pharmaceutical sector in India.

Nippon India Nifty Pharma ETF

Average daily traded value of the ETF is high

High Liquidity

Press Release

Alteration Of Capital and Fund Raising-XBRL

Cash Dividend

Stock market update: Nifty Pharma index 0.86%

The Nifty Pharma index closed 0.86 per cent at 22501.85.

Sun Pharma and Dr. Reddy’s emerging as strong bets in pharma sector: Sandip Sabharwal

​So, there will still be uncertainties around and most of the IT stocks have had a very strong rally, like if you look at the larger ones, they have had a decent rally but many have virtually moved up in a straight line and today traded valuations which are two-three times historical earnings for some of the mid-tier companies which would be unsustainable in my view.

Stock market update: Nifty Pharma index 0.25% in a weak market

The Nifty Pharma index was trading 0.25 per cent at 22754.45.

Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF

Price Chart

Key Metrics

AMC profile

Peers

Get more out of Tickertape, Go Pro!

Recent News

Stock market update: Nifty Pharma index 0.86%

Sun Pharma and Dr. Reddy’s emerging as strong bets in pharma sector: Sandip Sabharwal

Stock market update: Nifty Pharma index 0.25% in a weak market

Recent Events

Press Release AUROPHARMA

Alteration Of Capital and Fund Raising-XBRL MANKIND

Cash Dividend NATCOPHARM